Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

One Doc Shoulders Aside Criticism of Sunshine Database Payment
WSJ Pharmalot
Friday, October 3, 2014 - 8:05am
tags:
Physician Payment Sunshine Act, devices
Exclusive: Facebook plots first steps into healthcare
Yahoo/Reuters
Friday, October 3, 2014 - 7:58am
tags:
Facebook, social media, patients
EU OKs Eli Lilly's $5.4B bid for Novartis division
Yahoo/AP
Friday, October 3, 2014 - 7:57am
tags:
Europe, Eli Lilly, Novartis, animal health
Tougher U.S. Tax Rules Cited as Salix Ends Cosmo Deal
Bloomberg
Friday, October 3, 2014 - 7:51am
tags:
Salix, Cosmo Pharma, M&A
Takeda Accused of Putting Actos Profit Ahead of Safety
Bloomberg
Thursday, October 2, 2014 - 8:01pm
tags:
Takeda, Actos, Osaka, diabetes, cancer
Analyst Still Sees Zogenix Potentially Doubling
24/7 Wall St
Thursday, October 2, 2014 - 8:00pm
tags:
Zogenix, Zohydro ER
Arbor Pharmaceuticals explores $1 bln-plus sale - sources
Yahoo/Reuters
Thursday, October 2, 2014 - 7:57pm
tags:
Arbor Pharmaceuticals, M&A
Salix Said in Talks to Sell to Actavis as Allergan Fades
Bloomberg
Thursday, October 2, 2014 - 7:56pm
tags:
Salix, Actavis, Allergan, M&A
The Gators are Snapping as Hospira Gets Another FDA Warning Letter
WSJ Pharmalot
Thursday, October 2, 2014 - 10:56am
tags:
Hospira, FDA, warnings, drug manufacturing
Acceleron Hit Over Competitive Concerns, But Investors Overlook Rest of Pipeline
TheStreet.com
Thursday, October 2, 2014 - 10:54am
tags:
Acceleron, Bluebird Bio
EU to extend Zimmer, Biomet probe, clear Eli Lilly, Novartis deal - sources
Yahoo/Reuters
Thursday, October 2, 2014 - 10:34am
tags:
Europe, Zimmer, Biomet, Eli Lilly, Novartis, M&A, devices, animal heatlh
Intarcia's annual diabetes treatment aces two Phase III trials
Fierce Biotech
Thursday, October 2, 2014 - 10:28am
tags:
Intarcia, diabetes, devices, ITCA 650
Analyst: Edwards Lifesciences' Sapien 3 poised to lead TAVI market
Mass Device
Thursday, October 2, 2014 - 9:43am
tags:
Edwards Lifesciences, Sapien 3, TAVI, devices
Eli Lilly to drop development of lupus drug
Yahoo/Reuters
Thursday, October 2, 2014 - 9:35am
tags:
Eli Lilly, lupus, tabalumab
Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst
24/7 Wall St
Thursday, October 2, 2014 - 9:33am
tags:
Celgene, Novartis, Eli Lilly, JNJ, Bristol-Myers Squibb, Biogen Idec
How Much? A Glaxo Goof Remains in the Sunshine Database
WSJ Pharmalot
Thursday, October 2, 2014 - 8:50am
tags:
GSK, physician payments, Physician Payment Sunshine Act
ISS Says Allergan Should Seek Shareholder Approval For Acquisition
Bidness Etc.
Thursday, October 2, 2014 - 8:48am
tags:
Allergan, Valeant Pharmaceuticals, M&A, ISS
Allergan blueprints a big Texas expansion amid battle with spendthrift Valeant
Fierce Biotech
Thursday, October 2, 2014 - 8:16am
tags:
Allergan, Texas, Valeant Pharmaceuticals, drug manufacturing
Sanofi sets up a major R&D hub in booming Shanghai
Fierce Biotech
Thursday, October 2, 2014 - 8:12am
tags:
Sanofi, R&D, China
Boehringer Ingelheim invests more than €100m to expand manufacturing capacity in Germany
In-Pharma Technologist
Thursday, October 2, 2014 - 8:10am
tags:
Boehringer Ingelheim, Germany, drug manufacturing

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.